Asher Jones

Asher Jones

Asher is a science journalist based in Arlington, Virginia, and The Scientist’s editorial intern. She recently completed a PhD in entomology from Penn State University, and she was a 2020 AAAS Mass Media Fellow at Voice of America. You can find more of her work here.

Articles by Asher Jones
Moderna Developing Booster Shot for New Virus Variant B.1.351
Moderna Developing Booster Shot for New Virus Variant B.1.351
Asher Jones | Jan 25, 2021
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.
Bee Reports over the Past Century Indicate a Loss of Diversity
Bee Reports over the Past Century Indicate a Loss of Diversity
Asher Jones | Jan 22, 2021
An analysis of museum data and naturalists' observations finds that the number of bee species recorded has been declining since the 1990s. The first global, long-term study of bee trends adds to mounting evidence that the pollinators are in trouble worldwide.
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Asher Jones | Jan 19, 2021
It’s too early to know whether the L452R version of SARS-CoV-2 is highly infectious like the B.1.1.7 UK variant that is also spreading around the US.
Q&A: Global Insect Declines Due to “Death by a Thousand Cuts”
Q&A: Global Insect Declines Due to “Death by a Thousand Cuts”
Asher Jones | Jan 15, 2021
University of Connecticut entomologist David Wagner speaks with The Scientist about his biggest concerns for global insect populations and recommendations for actions to help save these tiny but important creatures.
Record Drop in US Cancer Death Rate
Record Drop in US Cancer Death Rate
Asher Jones | Jan 13, 2021
From 2017 to 2018, cancer deaths dropped by 2.4 percent, the largest single-year improvement recorded in 70 years of American Cancer Society annual cancer reports.
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
Asher Jones | Jan 11, 2021
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.